REGULATION OF THE ENDOTHELIAL-CELL UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR - EVIDENCE FOR CYCLIC-AMP DEPENDENT AND PROTEIN-KINASE-C DEPENDENT PATHWAYS

被引:42
作者
LANGER, DJ
KUO, A
KARIKO, K
AHUJA, M
KLUGHERZ, BD
IVANICS, KM
HOXIE, JA
WILLIAMS, WV
LIANG, BT
CINES, DB
BARNATHAN, ES
机构
[1] UNIV PENN,SCH MED,DEPT MED,CARDIOVASC SECT,503 JOHNSON PAVIL,BLDG CODE 6060,36TH & HAMILTON WALK,PHILADELPHIA,PA 19104
[2] UNIV PENN,SCH MED,DEPT MED,HEMATOL ONCOL SECT,PHILADELPHIA,PA 19104
[3] UNIV PENN,SCH MED,DEPT MED,RHEUMATOL SECT,PHILADELPHIA,PA 19104
关键词
UROKINASE; ENDOTHELIAL CELLS; RECEPTOR;
D O I
10.1161/01.RES.72.2.330
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Binding of urokinase-type plasminogen activator (u-PA) to specific receptors (u-PAR) on the surface of endothelial cells contributes to the regulation of plasmin-dependent processes such as fibrinolysis and angiogenesis. We studied the effect of raising intracellular levels of cyclic AMP (cAMP) and/or activating protein kinase C on the expression of u-PAR in cultured human umbilical vein endothelial cells (HUVEC). Incubation of HUVEC with forskolin stimulated a time- and concentration-dependent increase in the expression of u-PAR, measured both by an increase in the specific binding of radiolabeled single-chain u-PA (scu-PA) and by increased binding of anti-u-PAR antibodies. Maximal increase in u-PAR expression (81+/-11% above control, n=11) was not associated with a change in receptor affinity for scu-PA when HUVEC were incubated for 20 hours at 37-degrees-C with 50 muM forskolin. Receptor induction by forskolin was inhibited when HUVEC were preincubated with deoxyadenosine monophosphate (DAM), an inhibitor of adenylyl cyclase. A similar increase in receptor expression (128+/-27% above control, n=3) was induced by the cAMP analogue 8-bromoadenosine 3':5'-cyclic monophosphate (50 mM). Forskolin induced an approximately twofold increase in the expression of a single almost-equal-to 1.4-kb u-PAR messenger RNA (mRNA) transcript within 2 hours. Phorbol myristate acetate (PMA) also stimulated a time- and concentration-dependent increase in specific scu-PA binding. The maximal increase in u-PAR expression (254+/-27% above control, n=11) was observed when HUVEC were preincubated with 10 nM PMA for 20 hours. Induction of u-PAR by PMA was inhibited when HUVEC were preincubated with either cycloheximide or H7 but was unaffected by DAM. u-PAR induced by PMA showed a reduced affinity for scu-PA (K(d), 14+/-2 nM versus 3.6+/-0.6 nM, p<0.001; n=8). PMA stimulation for 20 hours resulted in a sixfold increase in a single almost-equal-to 1.4-kb u-PAR mRNA transcript, with increased levels detectable within 30 minutes. Coincubation of HUVEC with optimal concentrations of forskolin and PMA for 20 hours produced a fully additive increase in u-PAR expression at both the mRNA and protein levels. These data suggest that both cAMP-dependent and protein kinase C-dependent protein kinase pathways may independently regulate u-PAR expression in human endothelial cells.
引用
收藏
页码:330 / 340
页数:11
相关论文
共 33 条
  • [1] BARNATHAN ES, 1990, BLOOD, V76, P1795
  • [2] BARNATHAN ES, 1988, J BIOL CHEM, V263, P7792
  • [3] BARNATHAN ES, 1990, J BIOL CHEM, V265, P2865
  • [4] METHOD FOR TESTING FOR SYNERGY WITH ANY NUMBER OF AGENTS
    BERENBAUM, MC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1978, 137 (02) : 122 - 130
  • [5] BLASI F, 1988, Fibrinolysis, V2, P73, DOI 10.1016/0268-9499(88)90370-0
  • [6] BOOYSE FM, 1981, BLOOD, V58, P788
  • [7] CASTAGNA M, 1982, J BIOL CHEM, V257, P7847
  • [8] ACCESSIBILITY OF RECEPTOR-BOUND UROKINASE TO TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR
    CUBELLIS, MV
    ANDREASEN, P
    RAGNO, P
    MAYER, M
    DANO, K
    BLASI, F
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (13) : 4828 - 4832
  • [9] PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER
    DANO, K
    ANDREASEN, PA
    GRONDAHLHANSEN, J
    KRISTENSEN, P
    NIELSEN, LS
    SKRIVER, L
    [J]. ADVANCES IN CANCER RESEARCH, 1985, 44 : 139 - 266
  • [10] DEGEN JL, 1985, J BIOL CHEM, V260, P2426